EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploiting nanopore sequencing advances for tRNA sequencing of human cancer models

Adva Kochavi, Arno Velds, Maya Suzuki, Shinichiro Akichika, Tsutomu Suzuki iD, Roderick L Beijersbergen, Reuven Agami iD

NAR Cancer · 07.10.2025 · 7 (4)

DOI: 10.1093/narcan/zcaf044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NAR Cancer, online erschienen am 03.11.2025. Verfasst von Adva Kochavi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: RNA, Transfer, Nanopore Sequencing, Neoplasms, Sequence Analysis, RNA. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch Cancer Society, European Research Council, NWO National Roadmap for Large-Scale Research Infrastructures.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transfer RNAs (tRNAs) are essential regulators of protein synthesis, and dysregulation of their abundance and modification status is involved in many human diseases including cancer. Despite the rapid development of novel tRNA sequencing approaches, due to tRNAs’ stable secondary structure and abundant modification sites, the human tRNA landscape has remained mostly unexplored. Here, we evaluated the new RNA004 chemistry of Oxford Nanopore Technologies, that is integrated with updated Dorado base-caller models, for tRNA quantification and modification annotation in human cancer models. We demonstrated that this technology identifies variations in tRNA expression across cancer cell lines and in response to external stress conditions, with highly reproducible results. We also show that analysis of base-calling error rate can indicate the presence of known modifications, including the cancer-associated tRNAPhe-Wybutosine modification. Furthermore, implementing the updated Dorado modification-calling feature, we showed the potential of RNA004 tRNA-seq in predicting common tRNA modifications. We also pinpointed possible limitations and challenges associated with both modification calling methods. Overall, RNA004 tRNA-seq can potentially enhance our understanding of the human tRNAome by simultaneously analyzing both tRNA abundance and modifications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, TransferNanopore SequencingNeoplasmsSequence Analysis, RNAHumansCell Line, TumorRNA Processing, Post-Transcriptional

Substanzen

RNA, Transfer

Autor:innen und Institutionen

  • Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands.
  • NKI Genomics Core facility, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands.
  • Department of Chemistry and Biotechnology, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan.
  • Division of Molecular Carcinogenesis, The NKI Robotics and Screening Center, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands.
  • Erasmus MC, Rotterdam University, Wytemaweg 80, 3015 CN, Rotterdam, the Netherlands.

ORCID-Profile: Tsutomu Suzuki, Reuven Agami

Förderung

  • Dutch Cancer Society
  • European Research Council
  • NWO National Roadmap for Large-Scale Research Infrastructures
  • ERATO

Zitieren

APA

Kochavi, A., Velds, A., Suzuki, M., Akichika, S., Suzuki, T., Beijersbergen, R. L., & Agami, R. (2025). Exploiting nanopore sequencing advances for tRNA sequencing of human cancer models. NAR Cancer, 7(4). https://doi.org/10.1093/narcan/zcaf044

Vancouver

Kochavi A, Velds A, Suzuki M, Akichika S, Suzuki T, Beijersbergen RL, et al. Exploiting nanopore sequencing advances for tRNA sequencing of human cancer models. NAR Cancer. 2025;7(4). doi:10.1093/narcan/zcaf044

BibTeX
@article{Kochavi2025,
  author = {Kochavi, Adva and Velds, Arno and Suzuki, Maya and Akichika, Shinichiro and Suzuki, Tsutomu and Beijersbergen, Roderick L and Agami, Reuven},
  title = {Exploiting nanopore sequencing advances for tRNA sequencing of human cancer models},
  journal = {NAR Cancer},
  year = {2025},
  volume = {7},
  number = {4},
  doi = {10.1093/narcan/zcaf044}
}
Kostenlos starten →